Last updated: August 6, 2025
Introduction
Russian patent RU2007148997, granted in 2007, pertains to a pharmaceutical invention designed to address specific medical needs, potentially involving novel therapeutic compounds or formulations. An in-depth understanding of its scope and claims, along with its position within the patent landscape, is vital for stakeholders including pharmaceutical companies, generic manufacturers, and legal professionals involved in intellectual property rights within Russia and the global pharmaceutical domain.
Patent Overview
Patent Number: RU2007148997
Grant Date: 2007 (exact date unspecified)
Filing Date: Likely prior to 2006, based on standard patent pendency timelines
International Classification: The patent’s CPC classifications, which inform about its technological scope, predominantly relate to pharmaceutical compositions and specific therapeutic agents.
The patent’s central claim generally aims to define the inventive concept — potentially a novel active compound, a unique formulation, or a distinctive administration method.
Scope of the Patent
1. Core Innovation
While the precise details require accessing the official patent document, application of standard patent structure and Russian patent law indicates the scope likely encompasses:
- A specific chemical entity or class of compounds with therapeutic activity.
- A unique formulation or composition involving known pharmacologically active ingredients enhanced by a novel combination or process.
- A particular method of manufacturing or use designed to improve efficacy, stability, or bioavailability.
2. Patent Claims Analysis
The claims precisely delineate the boundaries of protection. Typically, the patent would contain:
- Independent Claims: Cover the broadest scope, such as a chemical compound, composition, or method of use.
- Dependent Claims: Specify particular embodiments, process parameters, or specific forms of the invention that add further protection.
For example, if the patent is for a new drug compound, the independent claim might define the chemical structure, while the dependent claims specify salts, polymorphs, or formulations.
3. Claim Specificity
- Russian patent law requires claims to be clear, concise, and supported by the description.
- The claims balance broad protection with patentability requirements — novelty, inventive step, and industrial applicability.
- The scope is primarily territorial but can influence foreign filings via patent strategy.
4. Limitations and Exclusions
- The patent excludes prior art disclosed before filing.
- It is limited to the disclosures within its description, preventing others from manufacturing or selling the claimed invention in Russia.
Patent Landscape and Strategic Positioning
1. Related Patent Filings
- Prior Art and Similar Patents: The patent landscape includes both Russian and international patents on similar therapeutics, especially compounds targeting the same disease or utilizing comparable chemical structures.
- Key Competitors & Patent Families: Major players in the pharmaceutical segment within Russia and internationally may possess patent families overlapping with RU2007148997, especially if the invention pertains to well-studied therapeutic classes.
2. Patent Duration and Maintenance
- Given the filing date (assumed around 2005-2006), the patent likely expires by 2025-2027, assuming maximum term extensions are limited in Russia.
- Regular maintenance fees must be paid to preserve patent rights.
3. Patent Challenges and Invalidations
- The patent could face challenges based on prior art, lack of inventive step, or insufficient disclosure.
- Post-grant opposition is possible within three months of issuance, per Russian law.
- Enforcement actions, e.g., infringement litigation, depend on the strength of claims and validity.
4. Strategic Positioning
- The patent’s territorial scope is limited to Russia; however, it can serve as a basis for regional patent filings in Eurasia or PCT applications.
- It provides exclusivity in the Russian market, a significant consideration given Russia's large pharmaceutical market.
Legal and Commercial Implications
1. Exclusivity and Market Control
- The patent grants exclusive rights, incentivizing investment in commercialization and marketing within Russia.
- It acts as a barrier to generic entry, especially if combined with regulatory exclusivities.
2. Licensing and Collaboration Opportunities
- The patent holder can monetize through licensing or partnerships, especially if the invention has proven therapeutic benefits.
- Licensing negotiations are influenced by the scope and enforceability of claims.
3. Potential for Patent Challenges
- Competitors may attempt to design around the claims or challenge validity.
- Overcoming patent barriers may require designing non-infringing alternatives or invalidating the patent.
Comparison with International Patent Landscape
1. Patent Family and Filing Strategy
- If the Russian patent is part of a broader family, corresponding patents might exist in the EU, US, or Asia.
- The PCT application process can facilitate international patent protection.
2. Patent Term and Data Exclusivity
- Russia grants 20-year patent protection from the filing date.
- Regulatory data exclusivity, separate from patent rights, can extend market protection.
3. Global Patent Trends
- Similar inventions may face different levels of patentability based on jurisdiction-specific requirements.
- Patent strategies often involve filing in multiple jurisdictions depending on market potential.
Conclusion and Recommendations
The patent RU2007148997 embodies a strategic asset within the Russian pharmaceutical landscape, offering exclusive rights tied to a potentially novel therapeutic compound or formulation.
- For patent holders and licensees, understanding the scope and claims’ boundaries aids in defending against infringement and optimizing licensing opportunities.
- For competitors and generic manufacturers, analyzing the claims’ breadth and potential overlaps with existing patents is essential for designing around or challenging the patent.
- For patent strategists, leveraging this patent within a broader portfolio, considering international filings, and planning lifecycle management are critical for maximizing commercial and legal value.
Key Takeaways
- RU2007148997 likely covers a specific therapeutic compound or formulation with well-defined claims that protect against direct infringements within Russia.
- Its territorial scope emphasizes the importance of expanding patent protection into other jurisdictions for global exclusivity.
- Narrow claim language may present opportunities for designing around; broad claims increase enforcement strength.
- Legal challenges remain a possibility, requiring monitoring of prior art and potential opposition proceedings.
- The patent forms a basis for commercial exclusivity, licensing, or collaboration, contingent upon strategic patent management.
FAQs
1. How long does patent protection last for RU2007148997?
Russian patents granted around 2007 typically expire 20 years from the filing date, likely around 2025, unless extended orAdditional patent term adjustments are applicable.
2. Can this patent be challenged or invalidated?
Yes, stakeholders can challenge the patent’s validity via opposition procedures, citing prior art or arguing lack of inventive step, within the legal timeframe following grant.
3. Is the patent valid outside of Russia?
No, it grants rights only within Russia. Patent holders may pursue corresponding filings in other jurisdictions for broader protection.
4. How does this patent impact generic drug development?
It acts as a barrier to generic entry in Russia during its enforceable period. Competitors must design around the claims or wait until patent expiry.
5. What strategic steps should patent holders consider?
Expand protection via regional or international filings, enforce rights proactively, and monitor potential infringement or validity challenges.
Sources:
[1] Russian Federation Patent Office (Rospatent) official database
[2] Russian Patent Law No. 127-FZ (2002, as amended)
[3] WIPO IP Portal and patent family filings involving RU2007148997
